Better Planning, for a Better Future
Whether you’re pregnant or thinking about becoming pregnant, there’s a lot to consider. Much of it is exciting, but there are also many unknowns. You may be concerned about genetic disorders. Genetic carrier screening can provide more insight.
What Is Carrier Screening?
Carrier screening is a type of genetic test—using a simple blood draw—that can tell you whether you and/or your partner carry a gene with an irregularity, called a mutation, for specific genetic disorders that may be passed on to your baby. When carrier screening is performed before or during pregnancy, it allows you to find out the likelihood of having a child with certain genetic disorders.
Please note – healthcare providers interested in ordering genetic carrier screening must contact the laboratory prior to sending samples 1-888-NTD-LABS (683-5227).
What Do The Results Mean?
What if you test positive?
The next step would be to speak to your doctor or make an appointment with a genetic counselor to review potential next steps. If you are found to be a carrier of an autosomal recessive disorder, screening for your partner will likely be recommended. If you and your partner are both found to be carriers of the same autosomal recessive genetic condition, there would be a 25% chance of having a child affected with that disorder.
What if you test negative?
A negative result significantly reduces the likelihood of being a carrier, but does not eliminate it entirely. There are no tests that can detect all genetic mutations.
Learn more about why NTD Eurofins has been the laboratory to trust for over 30 years.Learn More
Genetic carrier screening is performed through our sister laboratory, EGL Genetics Eurofins.
EGL Genetics has been providing superior, cutting-edge service for more than 47 years. Their expertise spans common and rare genetic disease testing, genomic variant interpretation, test development, and research. EGL Genetics is a CLIA-certified and CAP-accredited laboratory. They work with clients across the United States and from more than 45 countries to help improve patient diagnosis.